Viability and DNA damage responses of TPPII-deficient Myc- and Ras-transformed fibroblasts

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Tripeptidyl peptidase II (TPPII) is a large cytosolic protease implicated in tumor cell viability and proliferation.
• Previous studies suggested TPPII's role in tumor cell response to ionizing radiation-induced DNA damage.
• Targeting TPPII for cancer therapy was considered due to these prior findings.

Purpose of the Study:

• To investigate the role of TPPII in transformed cells after genetic deletion.
• To determine if TPPII is essential for the viability and proliferation of cancer cells.
• To assess TPPII's influence on the DNA damage response pathway in transformed cells.

Main Methods:

• Generated conditional TPPII knockout cell lines from primary fibroblasts using floxed alleles.
• Transformed fibroblasts with c-myc and H-ras oncogenes.
• Deleted TPPII using retroviral self-deleting Cre recombinase for genetic ablation.

Main Results:

• TPPII deletion had no discernible effect on basal cell survival or proliferation in transformed fibroblasts.
• Ionizing radiation-induced DNA damage response, including p53 activation and cell cycle arrest, was not influenced by TPPII status.
• Apoptosis and clonogenic cell death following radiation were unaffected by the absence of TPPII.

Conclusions:

• The study's findings do not support a critical role for TPPII in the viability and proliferation of transformed cells.
• TPPII does not appear to be essential for the p53-mediated DNA damage response in these cancer models.
• Results challenge the notion of TPPII as a general therapeutic target for enhancing tumor cell death or radiosensitivity.